Climbing Mount Everest and supporting international medical research!
I'm Helene, I'm 27 years old and I'm currently doing my residency in Anesthesiology and Intensive Care in France. My recent experience in a COVID Intensive Care Unit made me think about what is important in my life and the causes that I would like to support in the future. My project links two of my passions: medicine and sport.
I would like to climb Mount Everest, the highest summit in the world, in May 2021, and donate the excess of all the funds I raise to medical research in hepatic virology.
This website will allow you to discover my background in medicine and research, my passion for sport, as well as my YouTube videos.
During my medical studies, I was privileged to intern in Professor ZOULIM's INSERM U1052 internationally renowned medical research Unit in Lyon, France. This unit is collaborating with research teams worldwide.
This team specializes in hepatic virology and oncology and more specifically on hepatitis B (HBV). Their works concern virus mechanisms and the development of new antiviral treatments.
Professor Fabien ZOULIM
Professor Fabien ZOULIM is the Chair of the International Coalition to Eliminate HBV (ICE-HBV), an organization that is supported by the World Health Organization (WHO).
He is Professor of Medicine at Lyon University, France,
Head of the Hepatology Department, Hospices Civils de Lyon
Head of the Viral Hepatitis Research Laboratory at INSERM Unit 1052
Head of the ANRS “HBV cure” Task Force in France
I will donate all the individual donations and the excess of the sponsors of my Everest expedition to this medical research unit. The current context underscores just how important it is to contribute to medical research, and I am looking forward to the opportunity to play a part in that.
Medical Research: Professor ZOULIM Eliminating Hepatitis B
Here is an interview with Professor ZOULIM, director of the internationally renowned INSERM 1052 medical research unit, specialized in hepatitis B. Professor Zoulim explains the challenges of hepatitis B today, the new therapeutic strategies and the future discoveries to be expected.